Neuralink, Musk's Brain-Computer Interface Company, Launches First Human Trials Recruiting Patients with Quadriplegia and ALS

The brain implant startup, Neuralink, led by billionaire Elon Musk, is currently recruiting individuals with quadriplegia and amyotrophic lateral sclerosis (ALS) to participate in the company's first human clinical trial. The trial aims to evaluate the safety and functionality of the brain-computer interface implantation tools, with the ultimate goal of enabling paralyzed individuals to control external devices through thought. This marks a crucial step forward for Neuralink in advancing the clinical application of brain-computer interfaces following animal trials. The industry anticipates that it may take 2-4 years for Neuralink to receive approval for human implantation, but Musk is more optimistic, believing that if the trial goes smoothly, approval could be obtained as soon as six months. A successful human trial would provide Neuralink with valuable data to support the formal application for approval.

World's First! China's Intracranial Brain-Computer Interface Medical Device Approved for Market Launch, Marking a New Era of Clinical Application

The National Medical Products Administration approved the world's first intracranial brain-computer interface medical device for market, marking the official entry of this technology into clinical application. The system uses minimally invasive implantation and wireless power supply technology to help patients with hand function disorders regain motor function.

Sanqi Interactive's AI Ambition: How Li Yifei is Building the Future of Technology and the Hard-Core Universe?

Sanqi Interactive has expanded from gaming into AI investment, making strategic investments in cutting-edge technology companies such as Zhipu AI and Moonlight Dark Side. The goal is to use AI technology to enhance productivity in the gaming industry. With Zhipu AI's listing as the first global large model company, its market value has exceeded 57.8 billion HKD, demonstrating the initial success of its technological transformation.

OpenAI Invests Heavily in Brain-Computer Interface Startup Merge Labs, Paving the Way for Human-Machine Integration

The brain-computer interface company Merge Labs, co-founded by OpenAI's CEO, has completed a $250 million seed round with a valuation of $850 million, led by OpenAI. Unlike Neuralink's surgical implantation approach, the company adopts an non-invasive technology route, dedicated to connecting biological intelligence with artificial intelligence.

Qiangnao Technology Secures 2 Billion Yuan in Funding, Becomes Strongest Competitor to Neuralink

Qiangnao Technology completed approximately 2 billion yuan in funding, setting a record in the domestic brain-computer interface industry, with the scale second only to Neuralink. The investors include top institutions such as IDG Capital and HD International, indicating the high confidence of the capital market in the non-invasive brain-computer interface sector.

Brain-Computer Interface Elevated to National Strategic Technology! China's Market Size Will Exceed 120 Billion by 2040, AI Large Model Token Consumption Surges 300 Times

Brain-Computer Interface has officially been upgraded to a national strategic technology and included in the 14th Five-Year Plan. The market size is expected to grow from 3.2 billion yuan in 2024 to 120 billion yuan by 2040, with an annual growth rate of 26%. Sci-fi scenarios such as thought-controlled devices are accelerating into reality, driving the development of the digital economy.